ELI LILLY & Co is 422.9x more valuable than IDEAYA Biosciences, Inc. by market capitalization ($1.070 T vs $2.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IDYA | LLY |
|---|---|---|
| Market cap | $2.53 B | $1.070 T |
| US-listed rank | #1945 | #10 |
| Revenue (latest FY) | $218.71M | $65.18B |
| Net income (latest FY) | -$113.70M | $20.64B |
| Net margin | -52.0% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 477 | 989 |
ELI LILLY & Co is 422.9x more valuable than IDEAYA Biosciences, Inc. by market capitalization ($1.070 T vs $2.53 B).
In their latest fiscal years, IDEAYA Biosciences, Inc. reported $218.71M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: IDEAYA Biosciences, Inc. and ELI LILLY & Co, or browse the full rankings.